Current status of breast cancer prevention in China.
作者信息
Wang Fei, Yu Zhi-Gang
机构信息
Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, China.
出版信息
Chronic Dis Transl Med. 2015 Mar 20;1(1):2-8. doi: 10.1016/j.cdtm.2015.02.003. eCollection 2015 Mar.
Abstract
摘要
相似文献
1
Current status of breast cancer prevention in China.中国乳腺癌预防的现状。
Chronic Dis Transl Med. 2015 Mar 20;1(1):2-8. doi: 10.1016/j.cdtm.2015.02.003. eCollection 2015 Mar.
2
[Disparities of breast cancer burden between China and western countries and its implication].
Zhonghua Wai Ke Za Zhi. 2015 Dec 1;53(12):905-9.
3
[China faces a challenge of breast cancer prevention and control].[中国面临乳腺癌防治挑战]
Zhonghua Zhong Liu Za Zhi. 2016 Oct 23;38(10):798-800. doi: 10.3760/cma.j.issn.0253-3766.2016.10.018.
4
[Incidence and mortality of female breast cancer in China, 2014].《2014年中国女性乳腺癌的发病率与死亡率》
Zhonghua Zhong Liu Za Zhi. 2018 Mar 23;40(3):166-171. doi: 10.3760/cma.j.issn.0253-3766.2018.03.002.
5
[Status and trends of breast cancer mortality in Chinese females].中国女性乳腺癌死亡率的现状与趋势
Zhonghua Yu Fang Yi Xue Za Zhi. 2011 Feb;45(2):150-4.
6
Risk factors related to female breast cancer in regions of Northeast China: a 1:3 matched case-control population-based study.东北地区女性乳腺癌相关危险因素的病例对照研究：1:3 匹配基于人群的研究。
Chin Med J (Engl). 2012 Mar;125(5):733-40.
7
Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals.中国乳腺癌手术选择的现状及影响因素：一项对 110 家医院的全国横断面调查。
Oncologist. 2020 Oct;25(10):e1473-e1480. doi: 10.1634/theoncologist.2020-0001. Epub 2020 May 13.
8
Socioeconomic status index is an independent determinant of breast cancer screening practices: Evidence from Eastern China.社会经济地位指数是乳腺癌筛查实践的独立决定因素：来自中国东部的证据。
PLoS One. 2022 Dec 14;17(12):e0279107. doi: 10.1371/journal.pone.0279107. eCollection 2022.
9
[Current status and challenges of prevention and control of esophageal cancer in China].[中国食管癌防治的现状与挑战]
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Nov 6;53(11):1081-1083. doi: 10.3760/cma.j.issn.0253-9624.2019.11.001.
10
[China guideline for the screening and early detection of female breast cancer(2021, Beijing)].《中国女性乳腺癌筛查与早诊指南（2021年版，北京）》
Zhonghua Zhong Liu Za Zhi. 2021 Apr 23;43(4):357-382. doi: 10.3760/cma.j.cn112152-20210119-00061.
引用本文的文献
1
Exploring breast cancer associated-gene panel for next-generation sequencing and identifying new, pathogenic variants in breast cancer from western China.探索用于下一代测序的乳腺癌相关基因 panel 并鉴定来自中国西部的乳腺癌新致病变体。
J Cancer. 2025 Jan 13;16(4):1281-1295. doi: 10.7150/jca.101911. eCollection 2025.
2
The current diagnosis and treatment strategy of breast cancer based on multicentre retrospective data in Shaanxi province.基于陕西省多中心回顾性数据的乳腺癌当前诊断与治疗策略。
World J Surg Oncol. 2024 Aug 6;22(1):210. doi: 10.1186/s12957-024-03485-4.
3
Socioeconomic status index is an independent determinant of breast cancer screening practices: Evidence from Eastern China.社会经济地位指数是乳腺癌筛查实践的独立决定因素：来自中国东部的证据。
PLoS One. 2022 Dec 14;17(12):e0279107. doi: 10.1371/journal.pone.0279107. eCollection 2022.
4
Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives.亚洲的乳腺癌：发病率、死亡率、早期检测、乳房X光检查项目以及基于风险的筛查举措
Cancers (Basel). 2022 Aug 30;14(17):4218. doi: 10.3390/cancers14174218.
5
High Prevalence of Triple-Negative Breast Cancer in Southern Shaanxi Province, China.中国陕西省南部三阴性乳腺癌的高患病率。
Cancer Manag Res. 2021 Feb 17;13:1609-1615. doi: 10.2147/CMAR.S295085. eCollection 2021.
6
Reading High Breast Density Mammograms: Differences in Diagnostic Performance between Radiologists from Hong Kong SAR/Guangdong Province in China and Australia.阅读高乳腺密度乳房 X 光片：来自中国香港特别行政区/广东省和澳大利亚的放射科医生之间诊断性能的差异。
Asian Pac J Cancer Prev. 2020 Sep 1;21(9):2623-2629. doi: 10.31557/APJCP.2020.21.9.2623.
7
miR-17-5p promotes migration and invasion in breast cancer cells by repressing netrin 4.微小RNA-17-5p通过抑制网蛋白4促进乳腺癌细胞的迁移和侵袭。
Int J Clin Exp Pathol. 2019 May 1;12(5):1649-1657. eCollection 2019.
8
[Silencing RRM1 gene reverses paclitaxel resistance in human breast cancer cell line MCF- 7/R by inducing cell apoptosis].[沉默RRM1基因通过诱导细胞凋亡逆转人乳腺癌细胞系MCF-7/R对紫杉醇的耐药性]
Nan Fang Yi Ke Da Xue Xue Bao. 2019 Mar 30;39(3):304-312. doi: 10.12122/j.issn.1673-4254.2019.03.08.
9
Breast cancer screening programs: Review of merits, demerits, and recent recommendations practiced across the world.乳腺癌筛查项目：全球范围内实施的优点、缺点及近期建议综述。
J Microsc Ultrastruct. 2017 Apr-Jun;5(2):59-69. doi: 10.1016/j.jmau.2016.10.002. Epub 2016 Nov 28.
10
MicroRNA-10b expression in breast cancer and its clinical association.微小RNA-10b在乳腺癌中的表达及其临床关联。
PLoS One. 2018 Feb 6;13(2):e0192509. doi: 10.1371/journal.pone.0192509. eCollection 2018.
本文引用的文献
1
Report of cancer incidence and mortality in China, 2010.中国癌症发病率和死亡率报告，2010 年。
Ann Transl Med. 2014 Jul;2(7):61. doi: 10.3978/j.issn.2305-5839.2014.04.05.
2
Breast cancer awareness among women in Eastern China: a cross-sectional study.中国东部女性的乳腺癌知晓情况：一项横断面研究。
BMC Public Health. 2014 Sep 26;14:1004. doi: 10.1186/1471-2458-14-1004.
3
Cancer survival in China, 2003-2005: a population-based study.2003 - 2005年中国癌症生存率：一项基于人群的研究。
Int J Cancer. 2015 Apr 15;136(8):1921-30. doi: 10.1002/ijc.29227. Epub 2014 Oct 3.
4
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡：GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
5
Incidence and mortality of female breast cancer in Jiangsu, China.中国江苏省女性乳腺癌的发病率和死亡率。
Asian Pac J Cancer Prev. 2014;15(6):2727-32. doi: 10.7314/apjcp.2014.15.6.2727.
6
A systematic assessment of benefits and risks to guide breast cancer screening decisions.系统评估获益与风险以指导乳腺癌筛查决策。
JAMA. 2014 Apr 2;311(13):1327-35. doi: 10.1001/jama.2014.1398.
7
Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.基于风险的乳腺癌筛查策略的成本效益分析和利弊分析。
PLoS One. 2014 Feb 3;9(2):e86858. doi: 10.1371/journal.pone.0086858. eCollection 2014.
8
Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.乳腺钼靶联合乳腺超声与单纯乳腺钼靶用于平均风险女性乳腺癌筛查的比较
Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD009632. doi: 10.1002/14651858.CD009632.pub2.
9
Planning cancer control in Latin America and the Caribbean.规划拉丁美洲和加勒比地区的癌症控制。
Lancet Oncol. 2013 Apr;14(5):391-436. doi: 10.1016/S1470-2045(13)70048-2.
10
Obesity, diabetes mellitus, and the risk of female breast cancer in Eastern China.中国东部地区肥胖、糖尿病与女性乳腺癌风险的关系
World J Surg Oncol. 2013 Mar 16;11:71. doi: 10.1186/1477-7819-11-71.
Zotero 插件